BCL6 gene rearrangement has been associated with poor prognosis when a study 50 evaluating BCL6 translocation using FISH analysis found that translocation of BCL6 in DLBCL patients had significantly lower overall survival than those without translocation. The gene discussed is BCL6; the disease is diffuse large B-cell lymphoma.